ERBB2 and neoplasm: Immunotherapy is also thought to have potential applications in OS and many immune-related therapeutic indicators, including PD-1, PD-L1, HER2, IGF2R, CTLA-4, and GD2, are highly expressed in tumor samples [12,13,14,15,16,17,18].